Immune Checkpoint Inhibitors in the Treatment of Stage III NSCLC: A Primer for Managed Care Pharmacy

AMCP NSCLC Symposium Program Image
Watch the on-demand, CPE-certified Webcast and download slides from our AMCP 2018 live symposium where pharmacy and oncology experts review the rationale for checkpoint inhibitor therapy in unresectable stage III NSCLC, how to integrate checkpoint inhibitors into therapeutic approaches, and strategies for identifying and managing immune-related adverse events.
Mark M. Awad, MD, PhD
Sandra Cuellar, PharmD, BCOP
Ali McBride, PharmD, MS, BCOP, FAzPA

Downloadable Slideset

In this downloadable slideset, Ali McBride PharmD, MS, BCOP, FAzPA, explores the underlying rationale for immune checkpoint inhibitor therapy in the care of patients with stage III NSCLC.

Released: April 27, 2018

In this downloadable slideset, Mark M. Awad, MD, PhD, juxtaposes historical data for concurrent CRT with new evidence for immune checkpoint therapy in the care of patients with stage III NSCLC.

Released: April 27, 2018

In this downloadable slideset, Sandra Cuellar, PharmD, BCOP, reviews pharmacy perspectives in the assessment and management of adverse events associated with immune checkpoint therapy in the care of patients with stage III NSCLC.

Released: April 27, 2018

On-Demand Webcast

Watch this CPE-certified Webcast of a CCO symposium at AMCP 2018, where Mark M. Awad, MD, PhD; Sandra Cuellar, PharmD, BCOP; and Ali McBride, PharmD, MS, BCOP, FAzPA, review and discuss the latest data on immune checkpoint inhibitors for stage III NSCLC as they apply to pharmacists and managed care professionals.

Mark M. Awad, MD, PhD Sandra Cuellar, PharmD, BCOP Ali McBride, PharmD, MS, BCOP, FAzPA Pharmacists: 1.5 contact hours (0.15 CEUs) Released: June 12, 2018 Expiration: June 11, 2019
Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

This activity is supported by an educational grant from
AstraZeneca

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?